Evis Sala: Returning Home to Transform Healthcare
Major Win for Childhood Cancer Advocacy: UN Adopts GICC Target
Marty Makary: FDA Rejection Letters are Now Public
Tom Powles: Another Step Towards Curing Bladder Cancer
David Steensma: Ajax Therapeutics Receives Orphan Drug Designation by FDA for AJ1-11095 for the Treatment of Myelofibrosis
Maryam Lustberg: From Phase 2 Promise to Phase 3 Proof in Neuropathy Prevention
FDA Awarded a National Priority Voucher to Teclistamab with Daratumumab for R/R Multiple Myeloma
FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC
The SITC Clinical Immuno-Oncology Network (SCION) Workshop is an intimate, intensive clinical trial development program organized by the Society for Immunotherapy of Cancer (SITC), designed to address the unique challenges […]
The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a thorough understanding of current standards of care, molecular pathology, and novel treatment targets. The preceptorship will take place on February 18–19, 2026, in Lugano, Switzerland, […]
The Targeted Therapies of Lung Cancer (TTLC) 2026 Meeting, organized by the International Association for the Study of Lung Cancer (IASLC), is a premier event for experts dedicated to advancing […]
The AACR IO Conference 2026, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy, will take place from February 18–21, 2026, at JW Marriott Los Angeles L.A. Live. Led by Scientific Committee Chairs Nina Bhardwaj and Antoni Ribas, the event will focus on cutting-edge research in cancer immunology, highlighting breakthroughs in immuno-oncology (IO) […]
The 2026 International Cancer Neuroscience Symposium, hosted by The University of Texas MD Anderson Cancer Center Cancer Neuroscience Program and Wiley's Advanced Portfolio, is a three-day dynamic hybrid event scheduled for Wednesday, February 18, to Friday, February 20, 2026. The in-person component will be held at the TMC3 Collaborative Building in Houston, Texas. This biennial […]
The 2026 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day event scheduled for February 19-21, 2026. Organized by ASTRO (American Society for Radiation Oncology) and co-sponsored by other key medical societies, the symposium will be held both in-person in Palm Desert, California, and as a live virtual meeting online. The central theme for the […]
The Advocates Webinar: Modernizing Oncology Endpoints, hosted virtually by Friends of Cancer Research (Friends), is a free, advocates-focused session scheduled for Thursday, February 19, 2026, from 12:00 PM to 1:00 PM ET. The webinar will build upon the public meeting held earlier in the month, focusing on translating complex scientific and policy discussions into accessible, […]
The APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit is a two-day continuing medical education conference organized by Horizon CME, scheduled for February 20th – 21st, 2026, at the Circa Resort and Casino in Las Vegas, Nevada. The summit is specifically tailored for Advanced Practice Providers (APPs), including Nurse Practitioners (NPs), Physician Assistants (PAs), […]
The Highlights in GI Oncology conference, hosted by Horizon CME, is a two-day educational program providing the latest science and practice-changing advances from the world's premier GI oncology event, the ASCO Gastrointestinal Cancers Symposium. The CME initiative, designed for a multidisciplinary audience including oncologists, surgeons, and nurses, is scheduled for February 20–21, 2026, at the […]
The Oncology APP Leadership Forum 2026 is the 3rd annual two-day conference designed for current and aspiring Advanced Practice Provider (APP) leaders, managers, administrators, and directors in oncology. Scheduled for February 20–21, 2026, at the Circa Resort and Casino in Las Vegas, the forum focuses on equipping APP leaders with the knowledge and skills to […]
The 16th World ADC London, set to convene at ExCeL London from February 23–26, 2026, stands as Europe’s premier conference dedicated to Antibody-Drug Conjugates (ADCs). The central focus of the 2026 event is differentiation across the ADC value chain - from design to production - in response to the dominance of Topo1 and MMAE payloads and […]
The Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond is the European Association for Cancer Research’s (EACR) inaugural virtual conference on this topic, scheduled for February 24–25, 2026. The two-day virtual summit is dedicated to showcasing cutting-edge developments in immunotherapy, spanning from basic research to clinical applications, with a strong emphasis on […]